Warning
Amerisource Health Services LLC Recalls Meclizine Hydrochloride Tablets
This is a Class II recall. This product may cause temporary health problems or pose a slight threat of a serious nature.
Source: FDA
WarningRecall #D-0418-2026Drug / Pharmaceutical
Amerisource Health Services LLC Recalls Meclizine Hydrochloride Tablets
Amerisource Health Services LLC · Class II — Moderate Risk
Product Description
Meclizine Hydrochloride Tablets, USP 12.5 mg, (a) 50 Tablets [5 x 10] (NDC 60687-775-65) (b) 12.5 mg Individual Dose ( NDC 60687-775-11), Rx Only, Distributed by: American Health Packaging, Columbus, Ohio, 43217.
Reason for Recall
Failed tablet specifications.
FDA Classification
Class II — Moderate Risk
A situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
Distribution
U.S. Nationwide
Remedy
Consumers should stop using this product. Contact the recalling firm for further instructions regarding this product.
411 Press Analysis
The FDA classified this recall as Class II, indicating the pharmaceutical product may cause temporary health problems or poses a slight threat of a serious nature. Amerisource Health Services LLC initiated the recall on March 16, 2026 affecting 697 cartons. Failed tablet specifications. The product was distributed in U.S. Nationwide. Consumers should check their purchases and discontinue use of any affected product. Contact Amerisource Health Services LLC for further instructions.
Sources: FDA openFDA Enforcement Database
This recall appears in: Drug & Medication Defects.